150 related articles for article (PubMed ID: 38562982)
21. Pulse-mediated chemotherapy enhances local control and survival in a spontaneous canine model of primary mucosal melanoma.
Spugnini EP; Dragonetti E; Vincenzi B; Onori N; Citro G; Baldi A
Melanoma Res; 2006 Feb; 16(1):23-7. PubMed ID: 16432452
[TBL] [Abstract][Full Text] [Related]
22. Radiotherapy of oral malignant melanomas in dogs.
Blackwood L; Dobson JM
J Am Vet Med Assoc; 1996 Jul; 209(1):98-102. PubMed ID: 8926220
[TBL] [Abstract][Full Text] [Related]
23. Canine oral fibrosarcomas: a retrospective analysis of 65 cases (1998-2010).
Gardner H; Fidel J; Haldorson G; Dernell W; Wheeler B
Vet Comp Oncol; 2015 Mar; 13(1):40-7. PubMed ID: 23418993
[TBL] [Abstract][Full Text] [Related]
24. Multimodality treatment including ONCEPT for canine oral melanoma: A retrospective analysis of 131 dogs.
Turek M; LaDue T; Looper J; Nagata K; Shiomitsu K; Keyerleber M; Buchholz J; Gieger T; Hetzel S
Vet Radiol Ultrasound; 2020 Jul; 61(4):471-480. PubMed ID: 32323424
[TBL] [Abstract][Full Text] [Related]
25. Evaluation of cisplatin combined with piroxicam for the treatment of oral malignant melanoma and oral squamous cell carcinoma in dogs.
Boria PA; Murry DJ; Bennett PF; Glickman NW; Snyder PW; Merkel BL; Schlittler DL; Mutsaers AJ; Thomas RM; Knapp DW
J Am Vet Med Assoc; 2004 Feb; 224(3):388-94. PubMed ID: 14765798
[TBL] [Abstract][Full Text] [Related]
26. Safety and efficacy of a xenogeneic DNA vaccine encoding for human tyrosinase as adjunctive treatment for oral malignant melanoma in dogs following surgical excision of the primary tumor.
Grosenbaugh DA; Leard AT; Bergman PJ; Klein MK; Meleo K; Susaneck S; Hess PR; Jankowski MK; Jones PD; Leibman NF; Johnson MH; Kurzman ID; Wolchok JD
Am J Vet Res; 2011 Dec; 72(12):1631-8. PubMed ID: 22126691
[TBL] [Abstract][Full Text] [Related]
27. [Prognosis of canine oral (gingival) squamous cell carcinoma after surgical therapy. A retrospective analysis in 40 patients].
Kühnel S; Kessler M
Tierarztl Prax Ausg K Kleintiere Heimtiere; 2014; 42(6):359-66. PubMed ID: 25418424
[TBL] [Abstract][Full Text] [Related]
28. A retrospective study of 101 dogs with oral melanoma treated with a weekly or biweekly 6 Gy × 6 radiotherapy protocol.
Baja AJ; Kelsey KL; Ruslander DM; Gieger TL; Nolan MW
Vet Comp Oncol; 2022 Sep; 20(3):623-631. PubMed ID: 35338766
[TBL] [Abstract][Full Text] [Related]
29. Prognosis after surgical excision of canine melanomas.
Bostock DE
Vet Pathol; 1979 Jan; 16(1):32-40. PubMed ID: 462717
[TBL] [Abstract][Full Text] [Related]
30. Intralesional implant for treatment of primary oral malignant melanoma in dogs.
Kitchell BE; Brown DM; Luck EE; Woods LL; Orenberg EK; Bloch DA
J Am Vet Med Assoc; 1994 Jan; 204(2):229-36. PubMed ID: 8144382
[TBL] [Abstract][Full Text] [Related]
31. Use of alternating administration of carboplatin and doxorubicin in dogs with microscopic metastases after amputation for appendicular osteosarcoma: 50 cases (1999-2006).
Bacon NJ; Ehrhart NP; Dernell WS; Lafferty M; Withrow SJ
J Am Vet Med Assoc; 2008 May; 232(10):1504-10. PubMed ID: 18479240
[TBL] [Abstract][Full Text] [Related]
32. Predictors of outcome in dogs treated with adjuvant carboplatin for appendicular osteosarcoma: 65 cases (1996-2006).
Saam DE; Liptak JM; Stalker MJ; Chun R
J Am Vet Med Assoc; 2011 Jan; 238(2):195-206. PubMed ID: 21235373
[TBL] [Abstract][Full Text] [Related]
33. [Developmental studies on melanoma of the skin and mouth mucosa of dogs].
Frese K
Vet Pathol; 1978 Jul; 15(4):461-73. PubMed ID: 695220
[TBL] [Abstract][Full Text] [Related]
34. [Combined use of irradiation and DNA tumor vaccine to treat canine oral malignant melanoma: a pilot study].
Herzog A; Buchholz J; Ruess-Melzer K; Lang J; Kaser-Hotz B
Schweiz Arch Tierheilkd; 2013 Feb; 155(2):135-42. PubMed ID: 23385072
[TBL] [Abstract][Full Text] [Related]
35. A retrospective review of outcome and survival following surgery and adjuvant xenogeneic DNA vaccination in 32 dogs with oral malignant melanoma.
Treggiari E; Grant JP; North SM
J Vet Med Sci; 2016 Jun; 78(5):845-50. PubMed ID: 26781703
[TBL] [Abstract][Full Text] [Related]
36. Curative Intent Surgery of Oral Malignant Melanoma and Regional Lymph Node Biopsy Assessment in 25 Dogs: 2006-2017.
Raleigh ML; Smith MM; Taney K
J Vet Dent; 2021 Dec; 38(4):193-198. PubMed ID: 35014552
[TBL] [Abstract][Full Text] [Related]
37. Investigation of the effects of mTOR inhibitors rapamycin and everolimus in combination with carboplatin on canine malignant melanoma cells.
Bernard S; Poon AC; Tam PM; Mutsaers AJ
BMC Vet Res; 2021 Dec; 17(1):382. PubMed ID: 34895222
[TBL] [Abstract][Full Text] [Related]
38. Use of the melanoma vaccine in 38 dogs: The South African experience.
McLean JL; Lobetti RG
J S Afr Vet Assoc; 2015 Apr; 86(1):1246. PubMed ID: 26016668
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of metronomic cyclophosphamide chemotherapy as maintenance treatment for dogs with appendicular osteosarcoma following limb amputation and carboplatin chemotherapy.
Matsuyama A; Schott CR; Wood GA; Richardson D; Woods JP; Mutsaers AJ
J Am Vet Med Assoc; 2018 Jun; 252(11):1377-1383. PubMed ID: 29772973
[TBL] [Abstract][Full Text] [Related]
40. Evaluation of toxicities from combined metronomic and maximal-tolerated dose chemotherapy in dogs with osteosarcoma.
Bracha S; Walshaw R; Danton T; Holland S; Ruaux C; Obradovich J
J Small Anim Pract; 2014 Jul; 55(7):369-74. PubMed ID: 24803081
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
